Wheat IgE-mediated Food Allergy in European Patients: Alpha-amylase Inhibitors, Lipid Transfer Proteins and Low-molecular-weight Glutenins. Allergenic Molecules Recognized by Double-blind, Placebo-controlled Food Challenge
Overview
Authors
Affiliations
Background: Three main problems hamper the identification of wheat food allergens: (1) lack of a standardized procedure for extracting all of the wheat protein fractions; (2) absence of double-blind, placebo-controlled food challenge studies that compare the allergenic profile of Osborne's three protein fractions in subjects with real wheat allergy, and (3) lack of data on the differences in IgE-binding capacity between raw and cooked wheat.
Methods: Sera of 16 wheat-challenge-positive patients and 6 patients with wheat anaphylaxis, recruited from Italy, Denmark and Switzerland, were used for sodium dodecyl sulfate-polyacrylamide gel electrophoresis/immunoblotting of the three Osborne's protein fractions (albumin/globulin, gliadins and glutenins) of raw and cooked wheat. Thermal sensitivity of wheat lipid transfer protein (LTP) was investigated by spectroscopic approaches. IgE cross-reactivity between wheat and grass pollen was studied by blot inhibition.
Results: The most important wheat allergens were the alpha-amylase/trypsin inhibitor subunits, which were present in all three protein fractions of raw and cooked wheat. Other important allergens were a 9-kDa LTP in the albumin/globulin fraction and several low-molecular-weight (LMW) glutenin subunits in the gluten fraction. All these allergens showed heat resistance and lack of cross-reactivity to grass pollen allergens. LTP was a major allergen only in Italian patients.
Conclusions: The alpha-amylase inhibitor was confirmed to be the most important wheat allergen in food allergy and to play a role in wheat-dependent exercise-induced anaphylaxis, too. Other important allergens were LTP and the LMW glutenin subunits.
Malnutrition and Allergies: Tipping the Immune Balance towards Health.
Vassilopoulou E, Venter C, Roth-Walter F J Clin Med. 2024; 13(16).
PMID: 39200855 PMC: 11355500. DOI: 10.3390/jcm13164713.
Jorgensen R, Arul Arasan T, Srkalovic M, Van Antwerp C, Ng P, Gangur V Int J Mol Sci. 2024; 25(13).
PMID: 39000431 PMC: 11242169. DOI: 10.3390/ijms25137324.
Advances in Gluten Hypersensitivity: Novel Dietary-Based Therapeutics in Research and Development.
Jorgensen R, Devarahalli S, Shah Y, Gao H, Arul Arasan T, Ng P Int J Mol Sci. 2024; 25(8).
PMID: 38673984 PMC: 11050004. DOI: 10.3390/ijms25084399.
Faihs V, Schmalhofer V, Kugler C, Bent R, Scherf K, Lexhaller B Int J Mol Sci. 2024; 25(7).
PMID: 38612386 PMC: 11012217. DOI: 10.3390/ijms25073574.
Jorgensen R, Gao H, Arul Arasan T, Van Antwerp C, Sundar V, Ng P Int J Mol Sci. 2023; 24(24).
PMID: 38139075 PMC: 10743909. DOI: 10.3390/ijms242417247.